Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) had Return on Equity of -97.37% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-8.96M |
|
-- |
|
-- |
|
$9.53M |
|
$-9.53M |
|
$0.57M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-9.53M |
|
$-9.43M |
|
0.13M |
|
0.13M |
|
$-66.78 |
|
$-66.78 |
|
| Balance Sheet Financials | |
$14.93M |
|
-- |
|
$0.78M |
|
$15.71M |
|
$4.18M |
|
-- |
|
$2.32M |
|
$6.50M |
|
$9.20M |
|
$8.72M |
|
$9.20M |
|
0.26M |
|
| Cash Flow Statement Financials | |
$-7.86M |
|
$-1.89M |
|
$10.97M |
|
$2.40M |
|
$3.62M |
|
$1.22M |
|
$1.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-97.37% |
-102.76% |
|
-57.05% |
|
-97.37% |
|
$35.97 |
|
$-58.59 |
|
$-58.59 |
|